Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Total Laryngectomy Clinical Trial

Official title:
Second Amendment on Phase I Trial NO7VEG 'Assessment of a Next Generation Indwelling Provox Voice Rehabilitation System (Vega)': Vega Siri Addendum.

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the performance of a new voice prosthesis in comparison with the Provox2 and the Provox ActiValve voice prosthesis in 15 laryngectomized patients. Factors taken into account are clinician and patient satisfaction with the insertion system, patient satisfaction with voice, speech, performance, and maintenance. Voice and speech will also be evaluated for the different prostheses by means of perceptual evaluations and acoustic analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Total Laryngectomy

Clinical Trial Details

NCT number	NCT00743262
Study type	Interventional
Source	Atos Medical AB
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 2008
Completion date	April 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04491487` - Pre-operative Counselling in Laryngectomized Patients	N/A
Terminated	`NCT01948219` - ENTegral Artificial Larynx Clinical Trial	N/A
Completed	`NCT02601638` - Laryngectomy Education	N/A
Recruiting	`NCT05489965` - Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Recruiting	`NCT04650919` - Aortic Laryngeal Rehabilitation Graft	N/A
Terminated	`NCT00661570` - Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis	Phase 2
Completed	`NCT02739958` - Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx	N/A
Completed	`NCT00942903` - Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy	Phase 1
Completed	`NCT00884910` - Long Term Use of the Provox Vega 22.5	Phase 2